関連する実験動画
Updated: Jul 27, 2026

11:15
Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome
Published on: March 2, 2018
BDNF転写の低下は,MeCP2のカルシウム依存型リン酸化を伴う
Wen G Chen1, Qiang Chang, Yingxi Lin
1Division of Neuroscience, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
まとめ
メチル-CpG結合タンパク質2 (MeCP2) の変異がレット症候群を引き起こす. この研究では,MeCP2がニューロンにおけるBDNF遺伝子発現を抑制し,刺激時に放出され,遺伝子の活性化が可能になり,神経活動に依存する遺伝子調節におけるその役割を明らかにしています.
科学分野:
- 神経科学は神経科学である.
- 遺伝学 遺伝学とは
- 分子生物学は分子生物学である.
背景:
- レット症候群は,MECP2遺伝子の変異によって引き起こされる神経発達障害です.
- MeCP2タンパク質は転写抑制剤であるが,成熟したニューロンにおける特定の役割は不明である.
研究 の 目的:
- 転移後のニューロンにおけるMeCP2の機能を調査する.
- ニューロンの活動に対する遺伝子発現の調節におけるMeCP2のメカニズムを解明する.
主な方法:
- BDNF遺伝子プロモーターへのMeCP2結合の分析.
- MeCP2結合とBDNF発現に対する膜脱極化の影響を調査.
- MeCP2.2のカルシウム依存型リン酸化を研究する.
主要な成果:
- MeCP2は選択的にBDNFプロモーターIIIと結合し,その転写を抑制する.
- ニューロンの活動 (膜脱極化) は,カルシウム依存のリン酸化およびMeCP2.2の放出を誘導する.
- MeCP2の放出は,BDNFの遺伝子転写を促進する.
結論:
- MeCP2は,神経細胞の活動に依存する遺伝子発現の調節に不可欠です.
- MeCP2媒介の遺伝子制御の調節障害は,レット症候群の病理学に寄与する可能性があります.
関連する概念動画
RNA Polymerase II Accessory Proteins
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

